← Eichor
Condition: Hepatitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hepatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear S
Phase 3 · 1 location(s) · Huahui Health · NCT07499544Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis
Phase N/A · 6 location(s) · Hospices Civils de Lyon · NCT03825458Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT06638320Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Phase 1 · 1 location(s) · Changhai Hospital · NCT06885710Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07069569Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NA · 10 location(s) · Guangzhou 8th People's Hospital · NCT06947356EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endosc
NA · 1 location(s) · Chinese University of Hong Kong · NCT05597488VACcination of LIver Transplantation Candidates
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04446832VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06092333Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Phase N/A · 2 location(s) · MagIA Diagnostics · NCT07170748Research on Clinical Recovery and Maintenance Strategies for CHB
NA · 1 location(s) · Beijing Municipal Administration of Hospitals · NCT06803368Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Phase N/A · 1 location(s) · Huashan Hospital · NCT04896255TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04843852A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Phase 3 · 8 location(s) · GC Biopharma Corp · NCT05686759Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727EUS Guided Portal-systemic Pressure Gradient Measurement
Phase 1/Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT04633356Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06779864Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Phase 4 · 1 location(s) · Taichung Veterans General Hospital · NCT03933384Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
Phase 2 · 6 location(s) · Samer Gawrieh · NCT07060638Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Phase N/A · 1 location(s) · Taichung Veterans General Hospital · NCT05583006Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
NA · 9 location(s) · Johns Hopkins University · NCT05653232
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.